# FDA 483 - Acadia Pharmaceuticals Inc. - Unknown Date

Source: https://www.keypedia.com/records/483/acadia-pharmaceuticals-inc/47942bac-9cd9-446e-a5f4-82fdeae3dcd0

> FDA 483 for Acadia Pharmaceuticals Inc. on Unknown Date. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Acadia Pharmaceuticals Inc.
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Acadia Pharmaceuticals Inc. received a Form 483 for significant deficiencies in their bioresearch monitoring practices, including a repeat observation for failing to ensure proper study monitoring and enrolling ineligible subjects. The firm also failed to manage a non-compliant clinical investigator effectively and did not ensure proper retention and integrity of electronic records. These issues indicate serious concerns regarding the conduct and oversight of clinical trials.

## Related Officers

- [Business Analyst/Provider Enrollment Specialist](https://www.keypedia.com/people/lakecha-n-lewis/39b6305d-2a9f-448b-9a14-e412b43c8522)
- [issuing_officer](https://www.keypedia.com/people/kaitlyn-t-dang/640abfda-d492-4136-b11d-59ed9016bd97)

Company: https://www.keypedia.com/companies/acadia-pharmaceuticals-inc/28c1a8c0-e128-4d10-ac29-27aa95b67b55

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6